Searched for: subject:"DNA%5C+analysis"
(1 - 3 of 3)
document
Dankert-Roelse, J.E. (author), Bouvs, M.J. (author), Jakobs, B.S. (author), Janssens, H.M. (author), de Winter-de Groot, K.M. (author), Schonbeck, Y. (author), Gille, J.J.P. (author), Gulmans, V.A.M. (author), Verschoof-Puite, R.K. (author), Schielen, P.C.J.I. (author), Verkerk, P.H. (author)
Background Newborn screening for cystic fibrosis (NBSCF) was introduced in the Dutch NBS program in 2011 with a novel strategy. Methods Dutch NBSCF consisted of four steps: immuno-reactive trypsin (IRT), Pancreatitis-associated Protein (PAP), DNA analysis by Inno-LiPa (35 mutations), extended gene analysis (EGA) as fourth step and as safety net....
article 2019
document
Vernooij-van Langen, A.M.M. (author), Reijntjens, S. (author), van der Pal, S.M. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
Purpose: Most newborn screening (NBS) strategies for Cystic Fibrosis (CF) also identify carriers. However, it is unclear if parents want to be informed about their child's carrier status or not. Methods: Focus group discussions with pregnant couples to explore their opinions about disclosure of a carrier result for CF of their newborn. Results:...
article 2013
document
Vernooij-van Langen, A.M.M. (author), Reijntjens, S. (author), van der Pal, S.M. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
article 2011